{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,4]],"date-time":"2026-06-04T13:54:26Z","timestamp":1780581266655,"version":"3.54.1"},"reference-count":38,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2023,3,13]],"date-time":"2023-03-13T00:00:00Z","timestamp":1678665600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2023,3,13]],"date-time":"2023-03-13T00:00:00Z","timestamp":1678665600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"the Science and Technology Plan Project of the Health Commission of Jiangxi Province","award":["202140286"],"award-info":[{"award-number":["202140286"]}]},{"name":"the Science and Technology Plan Project of the Health Commission of Jiangxi Province","award":["202140286"],"award-info":[{"award-number":["202140286"]}]},{"name":"the Science and Technology Program of Administration of traditional Chinese Medicine of Jiangxi Province","award":["2021A151"],"award-info":[{"award-number":["2021A151"]}]},{"name":"the Science and Technology Program of Administration of traditional Chinese Medicine of Jiangxi Province","award":["2021A151"],"award-info":[{"award-number":["2021A151"]}]},{"name":"the Science and Technology Program of Administration of traditional Chinese Medicine of Jiangxi Province","award":["2021A151"],"award-info":[{"award-number":["2021A151"]}]},{"name":"the General Project of the Key R & D Program of the Department of Science and Technology of Jiangxi Province","award":["005062833097"],"award-info":[{"award-number":["005062833097"]}]},{"name":"the General Project of the Key R & D Program of the Department of Science and Technology of Jiangxi Province","award":["005062833097"],"award-info":[{"award-number":["005062833097"]}]},{"name":"the General Project of the Key R & D Program of the Department of Science and Technology of Jiangxi Province","award":["005062833097"],"award-info":[{"award-number":["005062833097"]}]},{"name":"the General Project of the Key R & D Program of the Department of Science and Technology of Jiangxi Province","award":["005062833097"],"award-info":[{"award-number":["005062833097"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Ophthalmol"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>The effectiveness of cycloplegia in delaying the progression of myopia and its application in refractive examination in children have been extensively studied, but there are still few studies on the effects of atropine\/tropicamide on ocular biological parameters. Therefore, the purpose of this study was to explore the effects of atropine\/tropicamide on children's ocular biological parameters in different age groups and the differences between them.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>This was a prospective observational study in which all school children were examined for dioptres and ocular biological parameters in the outpatient clinic, and 1% atropine or tropicamide was used for treatment. After examination, we enrolled the patients grouped by age (age from 2 to 12\u00a0years treated by atropine, 55 cases; age from 2 to 10\u00a0years treated by tropicamide, 70 cases; age from 14 to 17\u00a0years treated by tropicamide, 70 cases). The ocular biological parameters of each patient before and after cycloplegia were measured, and the difference and its absolute value were calculated for statistical analysis using an independent-samples t test.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      We compared the value and the absolute value of the differences in ocular biological parameters before and after cycloplegia in the same age group, and we found that the differences were not statistically significant (\n                      <jats:italic>P<\/jats:italic>\n                      \u2009&gt;\u20090.05). There were significant differences in the corresponding values of AL, K1 and ACD among the different age groups (\n                      <jats:italic>P<\/jats:italic>\n                      \u2009&lt;\u20090.05). Before cycloplegia, there were significant differences in AL, K, K1, K2 and ACD in different age groups (\n                      <jats:italic>P<\/jats:italic>\n                      \u2009&lt;\u20090.05). However, the differences in AL, K, K1, K2 and ACD among different age groups disappeared after cycloplegia (\n                      <jats:italic>P<\/jats:italic>\n                      \u2009&gt;\u20090.05).\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>This study demonstrated that atropine\/tropicamide have different effects on cycloplegia in children of different ages. The effects of atropine\/tropicamide on ocular biological parameters should be fully considered when evaluating the refractive state before refractive surgery or mydriasis optometry for children of different ages.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s12886-023-02840-5","type":"journal-article","created":{"date-parts":[[2023,3,26]],"date-time":"2023-03-26T16:28:28Z","timestamp":1679848108000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":6,"title":["Effects of atropine and tropicamide on ocular biological parameters in children: a prospective observational study"],"prefix":"10.1186","volume":"23","author":[{"given":"Yulin","family":"Tao","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohan","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jian","family":"Tan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jing","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaokang","family":"Cheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ping","family":"Xie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiansheng","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qiong","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jun","family":"Ouyang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,3,13]]},"reference":[{"issue":"7543","key":"2840_CR1","doi-asserted-by":"publisher","first-page":"276","DOI":"10.1038\/519276a","volume":"519","author":"E Dolgin","year":"2015","unstructured":"Dolgin E. The myopia boom. Nature. 2015;519(7543):276\u20138.","journal-title":"Nature"},{"issue":"1","key":"2840_CR2","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1038\/s41572-020-00231-4","volume":"6","author":"PN Baird","year":"2020","unstructured":"Baird PN, Saw SM, Lanca C, Guggenheim JA, Smith Iii EL, Zhou X, Matsui KO, Wu PC, Sankaridurg P, Chia A, et al. Myopia. Nat Rev Dis Primers. 2020;6(1):99.","journal-title":"Nat Rev Dis Primers"},{"issue":"5","key":"2840_CR3","doi-asserted-by":"publisher","first-page":"1036","DOI":"10.1016\/j.ophtha.2016.01.006","volume":"123","author":"BA Holden","year":"2016","unstructured":"Holden BA, Fricke TR, Wilson DA, Jong M, Naidoo KS, Sankaridurg P, Wong TY, Naduvilath TJ, Resnikoff S. Global Prevalence of Myopia and High Myopia and Temporal Trends from 2000 through 2050. Ophthalmology. 2016;123(5):1036\u201342.","journal-title":"Ophthalmology"},{"issue":"12","key":"2840_CR4","doi-asserted-by":"publisher","first-page":"1826","DOI":"10.1016\/j.ophtha.2017.05.030","volume":"124","author":"X Guo","year":"2017","unstructured":"Guo X, Fu M, Ding X, Morgan IG, Zeng Y, He M. Significant Axial Elongation with Minimal Change in Refraction in 3- to 6-Year-Old Chinese Preschoolers: The Shenzhen Kindergarten Eye Study. Ophthalmology. 2017;124(12):1826\u201338.","journal-title":"Ophthalmology"},{"issue":"10","key":"2840_CR5","doi-asserted-by":"publisher","first-page":"e029896","DOI":"10.1136\/bmjopen-2019-029896","volume":"9","author":"T Li","year":"2019","unstructured":"Li T, Jiang B, Zhou X. Axial length elongation in primary school-age children: a 3-year cohort study in Shanghai. BMJ Open. 2019;9(10):e029896.","journal-title":"BMJ Open"},{"issue":"9","key":"2840_CR6","doi-asserted-by":"publisher","first-page":"1017","DOI":"10.1001\/jamaophthalmol.2018.2658","volume":"136","author":"SK Wang","year":"2018","unstructured":"Wang SK, Guo Y, Liao C, Chen Y, Su G, Zhang G, Zhang L, He M. Incidence of and Factors Associated With Myopia and High Myopia in Chinese Children, Based on Refraction Without Cycloplegia. JAMA Ophthalmol. 2018;136(9):1017\u201324.","journal-title":"JAMA Ophthalmol"},{"issue":"2","key":"2840_CR7","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1111\/cxo.13128","volume":"104","author":"L Ye","year":"2021","unstructured":"Ye L, Li S, Shi Y, Yin Y, He J, Zhu J, Xu X. Comparisons of atropine versus cyclopentolate cycloplegia in myopic children. Clin Exp Optom. 2021;104(2):143\u201350.","journal-title":"Clin Exp Optom"},{"key":"2840_CR8","doi-asserted-by":"crossref","unstructured":"Major E, Dutson T, Moshirfar M. Cycloplegia in Children: An Optometrist\u2019s Perspective. Clin Optom (Auckl). 2020;12:129\u201333.","DOI":"10.2147\/OPTO.S217645"},{"issue":"2","key":"2840_CR9","doi-asserted-by":"publisher","first-page":"160","DOI":"10.1111\/cxo.12829","volume":"102","author":"T Li","year":"2019","unstructured":"Li T, Zhou X, Zhu J, Tang X, Gu X. Effect of cycloplegia on the measurement of refractive error in Chinese children. Clin Exp Optom. 2019;102(2):160\u20135.","journal-title":"Clin Exp Optom"},{"issue":"2","key":"2840_CR10","doi-asserted-by":"publisher","first-page":"101","DOI":"10.4103\/jovr.jovr_196_17","volume":"13","author":"A Bagheri","year":"2018","unstructured":"Bagheri A, Feizi M, Shafii A, Faramarzi A, Tavakoli M, Yazdani S. Effect of Cycloplegia on Corneal Biometrics and Refractive State. J Ophthalmic Vis Res. 2018;13(2):101\u20139.","journal-title":"J Ophthalmic Vis Res"},{"issue":"9","key":"2840_CR11","doi-asserted-by":"publisher","first-page":"1113","DOI":"10.1097\/OPX.0000000000000339","volume":"91","author":"HC Cheng","year":"2014","unstructured":"Cheng HC, Hsieh YT. Short-term refractive change and ocular parameter changes after cycloplegia. Optom Vis Sci. 2014;91(9):1113\u20137.","journal-title":"Optom Vis Sci"},{"issue":"1","key":"2840_CR12","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1016\/j.ophtha.2012.07.057","volume":"120","author":"T Hiraoka","year":"2013","unstructured":"Hiraoka T, Miyata K, Nakamura Y, Miyai T, Ogata M, Okamoto F, Oshika T. Influences of cycloplegia with topical atropine on ocular higher-order aberrations. Ophthalmology. 2013;120(1):8\u201313.","journal-title":"Ophthalmology"},{"issue":"2","key":"2840_CR13","doi-asserted-by":"publisher","first-page":"111","DOI":"10.4103\/tjo.tjo_110_18","volume":"10","author":"MC Ho","year":"2020","unstructured":"Ho MC, Hsieh YT, Shen EP, Hsu WC, Cheng HC. Short-term refractive and ocular parameter changes after topical atropine. Taiwan J Ophthalmol. 2020;10(2):111\u20135.","journal-title":"Taiwan J Ophthalmol"},{"issue":"2","key":"2840_CR14","doi-asserted-by":"publisher","first-page":"107","DOI":"10.5935\/0004-2749.20210015","volume":"84","author":"A Bahar","year":"2021","unstructured":"Bahar A, Pekel G. The effects of pharmacological accommodation and cycloplegia on axial length and choroidal thickness. Arq Bras Oftalmol. 2021;84(2):107\u201312.","journal-title":"Arq Bras Oftalmol"},{"issue":"4","key":"2840_CR15","doi-asserted-by":"publisher","first-page":"260","DOI":"10.3928\/01913913-20180327-05","volume":"55","author":"UK Raina","year":"2018","unstructured":"Raina UK, Gupta SK, Gupta A, Goray A, Saini V. Effect of Cycloplegia on Optical Biometry in Pediatric Eyes. J Pediatr Ophthalmol Strabismus. 2018;55(4):260\u20135.","journal-title":"J Pediatr Ophthalmol Strabismus"},{"issue":"2","key":"2840_CR16","doi-asserted-by":"publisher","first-page":"676","DOI":"10.1038\/s41433-020-01131-3","volume":"35","author":"I Tuncer","year":"2021","unstructured":"Tuncer I, Zengin MO, Yildiz S. The effect of cycloplegia on the ocular biometry and intraocular lens power based on age. Eye (Lond). 2021;35(2):676\u201381.","journal-title":"Eye (Lond)"},{"issue":"5","key":"2840_CR17","doi-asserted-by":"publisher","first-page":"e461","DOI":"10.1111\/j.1755-3768.2011.02122.x","volume":"89","author":"M Palamar","year":"2011","unstructured":"Palamar M, Egrilmez S, Uretmen O, Yagci A, Kose S. Influences of cyclopentolate hydrochloride on anterior segment parameters with Pentacam in children. Acta Ophthalmol. 2011;89(5):e461-465.","journal-title":"Acta Ophthalmol"},{"issue":"4","key":"2840_CR18","doi-asserted-by":"publisher","first-page":"404","DOI":"10.1097\/01.ico.0000214205.29823.f6","volume":"25","author":"L Gao","year":"2006","unstructured":"Gao L, Fan H, Cheng AC, Wang Z, Lam DS. The effects of eye drops on corneal thickness in adult myopia. Cornea. 2006;25(4):404\u20137.","journal-title":"Cornea"},{"issue":"2","key":"2840_CR19","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1111\/cxo.12465","volume":"100","author":"Y Zeng","year":"2017","unstructured":"Zeng Y, Gao JH. Effects of Mydrin eye-drops on central corneal thickness values in adult patients with myopia. Clin Exp Optom. 2017;100(2):151\u20134.","journal-title":"Clin Exp Optom"},{"issue":"4","key":"2840_CR20","doi-asserted-by":"publisher","first-page":"309","DOI":"10.5301\/ejo.5000568","volume":"25","author":"A Rodriguez-Raton","year":"2015","unstructured":"Rodriguez-Raton A, Jimenez-Alvarez M, Arteche-Limousin L, Mediavilla-Pena E, Larrucea-Martinez I. Effect of pupil dilation on biometry measurements with partial coherence interferometry and its effect on IOL power formula calculation. Eur J Ophthalmol. 2015;25(4):309\u201314.","journal-title":"Eur J Ophthalmol"},{"issue":"5","key":"2840_CR21","doi-asserted-by":"publisher","first-page":"1024","DOI":"10.1016\/j.jcrs.2003.10.040","volume":"30","author":"K Saitoh","year":"2004","unstructured":"Saitoh K, Yoshida K, Hamatsu Y, Tazawa Y. Changes in the shape of the anterior and posterior corneal surfaces caused by mydriasis and miosis: detailed analysis. J Cataract Refract Surg. 2004;30(5):1024\u201330.","journal-title":"J Cataract Refract Surg"},{"issue":"3","key":"2840_CR22","doi-asserted-by":"publisher","first-page":"387","DOI":"10.1007\/s40123-019-0187-5","volume":"8","author":"H Momeni-Moghaddam","year":"2019","unstructured":"Momeni-Moghaddam H, Maddah N, Wolffsohn JS, Etezad-Razavi M, Zarei-Ghanavati S, AkhavanRezayat A, Moshirfar M. The Effect of Cycloplegia on the Ocular Biometric and Anterior Segment Parameters: A Cross-Sectional Study. Ophthalmol Ther. 2019;8(3):387\u201395.","journal-title":"Ophthalmol Ther"},{"issue":"12","key":"2840_CR23","doi-asserted-by":"publisher","first-page":"1691","DOI":"10.1097\/OPX.0b013e3182772f4f","volume":"89","author":"J Huang","year":"2012","unstructured":"Huang J, McAlinden C, Su B, Pesudovs K, Feng Y, Hua Y, Yang F, Pan C, Zhou H, Wang Q. The effect of cycloplegia on the lenstar and the IOLMaster biometry. Optom Vis Sci. 2012;89(12):1691\u20136.","journal-title":"Optom Vis Sci"},{"key":"2840_CR24","doi-asserted-by":"publisher","first-page":"3437125","DOI":"10.1155\/2016\/3437125","volume":"2016","author":"N Polat","year":"2016","unstructured":"Polat N, Gunduz A. Effect of Cycloplegia on Keratometric and Biometric Parameters in Keratoconus. J Ophthalmol. 2016;2016:3437125.","journal-title":"J Ophthalmol"},{"issue":"1","key":"2840_CR25","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1097\/OPX.0000000000000748","volume":"93","author":"SW Chang","year":"2016","unstructured":"Chang SW, Lo AY, Su PF. Anterior Segment Biometry Changes with Cycloplegia in Myopic Adults. Optom Vis Sci. 2016;93(1):12\u20138.","journal-title":"Optom Vis Sci"},{"issue":"4","key":"2840_CR26","doi-asserted-by":"publisher","first-page":"364","DOI":"10.1111\/cxo.12839","volume":"102","author":"P Cho","year":"2019","unstructured":"Cho P, Tan Q. Myopia and orthokeratology for myopia control. Clin Exp Optom. 2019;102(4):364\u201377.","journal-title":"Clin Exp Optom"},{"issue":"4","key":"2840_CR27","doi-asserted-by":"publisher","first-page":"322","DOI":"10.1016\/j.clae.2020.03.018","volume":"43","author":"MA Bullimore","year":"2020","unstructured":"Bullimore MA, Johnson LA. Overnight orthokeratology. Cont Lens Anterior Eye. 2020;43(4):322\u201332.","journal-title":"Cont Lens Anterior Eye"},{"issue":"2","key":"2840_CR28","doi-asserted-by":"publisher","first-page":"240","DOI":"10.1016\/j.clae.2021.02.003","volume":"44","author":"SJ Vincent","year":"2021","unstructured":"Vincent SJ, Cho P, Chan KY, Fadel D, Ghorbani-Mojarrad N, Gonzalez-Meijome JM, Johnson L, Kang P, Michaud L, Simard P, et al. CLEAR - Orthokeratology. Cont Lens Anterior Eye. 2021;44(2):240\u201369.","journal-title":"Cont Lens Anterior Eye"},{"issue":"14","key":"2840_CR29","doi-asserted-by":"publisher","first-page":"DES109","DOI":"10.1167\/iovs.17-23538","volume":"59","author":"I Toda","year":"2018","unstructured":"Toda I. Dry Eye After LASIK. Invest Ophthalmol Vis Sci. 2018;59(14):DES109\u201315.","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"1","key":"2840_CR30","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1076\/soph.18.1.2.14074","volume":"18","author":"R Ambrosio Jr","year":"2003","unstructured":"Ambrosio R Jr, Wilson S. LASIK vs LASEK vs PRK: advantages and indications. Semin Ophthalmol. 2003;18(1):2\u201310.","journal-title":"Semin Ophthalmol"},{"issue":"6","key":"2840_CR31","doi-asserted-by":"publisher","first-page":"2091","DOI":"10.1007\/s10792-021-01766-5","volume":"41","author":"M Mimouni","year":"2021","unstructured":"Mimouni M, Pokroy R, Rabina G, Kaiserman I. LASIK versus PRK for high astigmatism. Int Ophthalmol. 2021;41(6):2091\u20138.","journal-title":"Int Ophthalmol"},{"issue":"4","key":"2840_CR32","doi-asserted-by":"publisher","first-page":"421","DOI":"10.1016\/S0002-9394(99)00455-9","volume":"129","author":"AD Negrel","year":"2000","unstructured":"Negrel AD, Maul E, Pokharel GP, Zhao J, Ellwein LB. Refractive Error Study in Children: sampling and measurement methods for a multi-country survey. Am J Ophthalmol. 2000;129(4):421\u20136.","journal-title":"Am J Ophthalmol"},{"issue":"11","key":"2840_CR33","doi-asserted-by":"publisher","first-page":"1185","DOI":"10.1001\/jamaophthalmol.2020.3830","volume":"138","author":"MX Repka","year":"2020","unstructured":"Repka MX. Myopia Control With Low-Dose Atropine Eyedrops. JAMA Ophthalmol. 2020;138(11):1185\u20136.","journal-title":"JAMA Ophthalmol"},{"issue":"1","key":"2840_CR34","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1016\/j.ophtha.2018.08.024","volume":"126","author":"P Sankaridurg","year":"2019","unstructured":"Sankaridurg P, Tran HDM. The Lowdown on Low-Concentration Atropine for Myopia Progression. Ophthalmology. 2019;126(1):125\u20136.","journal-title":"Ophthalmology"},{"issue":"9","key":"2840_CR35","doi-asserted-by":"publisher","first-page":"1367","DOI":"10.1016\/j.ophtha.2021.01.026","volume":"128","author":"R Saxena","year":"2021","unstructured":"Saxena R, Dhiman R, Gupta V, Kumar P, Matalia J, Roy L, Swaminathan M, Phuljhele S, Velpandian T, Sharma N. Atropine for the Treatment of Childhood Myopia in India: Multicentric Randomized Trial. Ophthalmology. 2021;128(9):1367\u20139.","journal-title":"Ophthalmology"},{"issue":"3","key":"2840_CR36","doi-asserted-by":"publisher","first-page":"303","DOI":"10.1001\/jamaophthalmol.2017.6638","volume":"136","author":"MA Bullimore","year":"2018","unstructured":"Bullimore MA, Berntsen DA. Low-Dose Atropine for Myopia Control: Considering All the Data. JAMA Ophthalmol. 2018;136(3):303.","journal-title":"JAMA Ophthalmol"},{"issue":"11","key":"2840_CR37","doi-asserted-by":"publisher","first-page":"1178","DOI":"10.1001\/jamaophthalmol.2020.3820","volume":"138","author":"S Wei","year":"2020","unstructured":"Wei S, Li SM, An W, Du J, Liang X, Sun Y, Zhang D, Tian J, Wang N. Safety and Efficacy of Low-Dose Atropine Eyedrops for the Treatment of Myopia Progression in Chinese Children: A Randomized Clinical Trial. JAMA Ophthalmol. 2020;138(11):1178\u201384.","journal-title":"JAMA Ophthalmol"},{"issue":"12","key":"2840_CR38","doi-asserted-by":"publisher","first-page":"1603","DOI":"10.1016\/j.ophtha.2020.06.004","volume":"127","author":"FF Li","year":"2020","unstructured":"Li FF, Kam KW, Zhang Y, Tang SM, Young AL, Chen LJ, Tham CC, Pang CP, Yam JC. Differential Effects on Ocular Biometrics by 0.05%, 0.025%, and 0.01% Atropine: Low-Concentration Atropine for Myopia Progression Study. Ophthalmology. 2020;127(12):1603\u201311.","journal-title":"Ophthalmology"}],"container-title":["BMC Ophthalmology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12886-023-02840-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12886-023-02840-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12886-023-02840-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,3,26]],"date-time":"2023-03-26T16:29:32Z","timestamp":1679848172000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcophthalmol.biomedcentral.com\/articles\/10.1186\/s12886-023-02840-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,3,13]]},"references-count":38,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2023,12]]}},"alternative-id":["2840"],"URL":"https:\/\/doi.org\/10.1186\/s12886-023-02840-5","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.3.rs-1954805\/v1","asserted-by":"object"}]},"ISSN":["1471-2415"],"issn-type":[{"value":"1471-2415","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,3,13]]},"assertion":[{"value":"12 August 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 March 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 March 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The implementation of this study followed the Declaration of Helsinki. This study protocol was reviewed and approved by the ethics committee of Jiujiang No 1 Peoples Hospital (Affiliated Jiujiang Hospital of Nanchang University) in China, approval number JJSDYRMYY-YXLL-2022\u2013243. Written informed consent for study participation was obtained from a parent or legal guardian of the participants in this study at the time of study enrolment. Their parent or legal guardian has consented to the submission of the case report to the journal.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"96"}}